Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cornea | 32 | 2024 | 58 | 4.190 |
Why?
|
| Keratoconus | 15 | 2023 | 16 | 3.090 |
Why?
|
| Myopia | 14 | 2023 | 26 | 2.610 |
Why?
|
| Refractive Errors | 13 | 2022 | 25 | 2.450 |
Why?
|
| Visual Acuity | 21 | 2023 | 97 | 2.280 |
Why?
|
| Down Syndrome | 9 | 2022 | 29 | 2.260 |
Why?
|
| Corneal Topography | 24 | 2023 | 26 | 2.220 |
Why?
|
| Vision Screening | 6 | 2022 | 21 | 1.870 |
Why?
|
| Vision Disorders | 5 | 2020 | 58 | 1.360 |
Why?
|
| Anterior Chamber | 5 | 2020 | 10 | 1.270 |
Why?
|
| Lasers, Excimer | 6 | 2023 | 7 | 1.250 |
Why?
|
| Photorefractive Keratectomy | 5 | 2023 | 6 | 1.230 |
Why?
|
| Refraction, Ocular | 17 | 2023 | 29 | 1.190 |
Why?
|
| Photochemotherapy | 6 | 2023 | 39 | 1.030 |
Why?
|
| Lens Implantation, Intraocular | 3 | 2015 | 7 | 0.990 |
Why?
|
| Phacoemulsification | 3 | 2015 | 9 | 0.990 |
Why?
|
| Astigmatism | 6 | 2021 | 8 | 0.970 |
Why?
|
| Iran | 26 | 2022 | 190 | 0.950 |
Why?
|
| Cross-Linking Reagents | 7 | 2023 | 51 | 0.900 |
Why?
|
| Humans | 76 | 2024 | 37093 | 0.780 |
Why?
|
| Evaluation Studies as Topic | 1 | 2020 | 54 | 0.750 |
Why?
|
| Keratomileusis, Laser In Situ | 3 | 2023 | 4 | 0.750 |
Why?
|
| Academies and Institutes | 1 | 2020 | 37 | 0.740 |
Why?
|
| Eyeglasses | 3 | 2016 | 21 | 0.730 |
Why?
|
| Riboflavin | 6 | 2022 | 24 | 0.730 |
Why?
|
| Universities | 2 | 2020 | 442 | 0.730 |
Why?
|
| Mitomycin | 3 | 2015 | 11 | 0.710 |
Why?
|
| Alkylating Agents | 3 | 2015 | 13 | 0.710 |
Why?
|
| Prospective Studies | 17 | 2022 | 1378 | 0.690 |
Why?
|
| Female | 55 | 2023 | 20969 | 0.690 |
Why?
|
| Male | 52 | 2022 | 20025 | 0.690 |
Why?
|
| Adult | 44 | 2023 | 11712 | 0.680 |
Why?
|
| Hyperopia | 5 | 2019 | 7 | 0.640 |
Why?
|
| Amblyopia | 4 | 2019 | 13 | 0.590 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 215 | 0.570 |
Why?
|
| Tears | 2 | 2014 | 11 | 0.570 |
Why?
|
| Minority Groups | 2 | 2023 | 596 | 0.560 |
Why?
|
| Schools | 1 | 2018 | 260 | 0.560 |
Why?
|
| Endothelium, Corneal | 3 | 2020 | 5 | 0.550 |
Why?
|
| Aniridia | 1 | 2015 | 2 | 0.540 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 15 | 0.540 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 17 | 0.540 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2015 | 6 | 0.540 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 5 | 2017 | 14 | 0.530 |
Why?
|
| Photosensitizing Agents | 7 | 2023 | 49 | 0.520 |
Why?
|
| Young Adult | 22 | 2021 | 4268 | 0.520 |
Why?
|
| Middle Aged | 32 | 2021 | 10129 | 0.490 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 404 | 0.480 |
Why?
|
| Pseudophakia | 2 | 2012 | 2 | 0.480 |
Why?
|
| Refractometry | 1 | 2014 | 14 | 0.470 |
Why?
|
| Aging | 8 | 2022 | 664 | 0.460 |
Why?
|
| Child | 15 | 2022 | 3131 | 0.460 |
Why?
|
| Photography | 3 | 2011 | 46 | 0.460 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 276 | 0.440 |
Why?
|
| Adolescent | 21 | 2021 | 5363 | 0.430 |
Why?
|
| Cross-Sectional Studies | 20 | 2020 | 2721 | 0.420 |
Why?
|
| Cataract Extraction | 4 | 2015 | 16 | 0.400 |
Why?
|
| Collagen | 4 | 2022 | 172 | 0.380 |
Why?
|
| Child, Preschool | 7 | 2022 | 1418 | 0.370 |
Why?
|
| Lenses, Intraocular | 1 | 2010 | 6 | 0.370 |
Why?
|
| Pupil | 3 | 2020 | 8 | 0.360 |
Why?
|
| Descemet Membrane | 1 | 2009 | 1 | 0.340 |
Why?
|
| Corneal Transplantation | 1 | 2009 | 2 | 0.340 |
Why?
|
| Follow-Up Studies | 9 | 2022 | 974 | 0.340 |
Why?
|
| Corneal Diseases | 2 | 2024 | 9 | 0.340 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 18 | 0.330 |
Why?
|
| Prevalence | 11 | 2022 | 1455 | 0.320 |
Why?
|
| Contrast Sensitivity | 4 | 2018 | 31 | 0.310 |
Why?
|
| Corneal Surgery, Laser | 1 | 2007 | 1 | 0.310 |
Why?
|
| Aged | 13 | 2019 | 6741 | 0.300 |
Why?
|
| Retrospective Studies | 7 | 2019 | 2026 | 0.290 |
Why?
|
| Biomedical Research | 2 | 2023 | 400 | 0.290 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 935 | 0.280 |
Why?
|
| Students | 2 | 2023 | 519 | 0.280 |
Why?
|
| Strabismus | 2 | 2016 | 17 | 0.270 |
Why?
|
| Postoperative Period | 4 | 2015 | 27 | 0.270 |
Why?
|
| Retinoscopy | 4 | 2021 | 11 | 0.270 |
Why?
|
| Reference Values | 6 | 2020 | 212 | 0.250 |
Why?
|
| Anisometropia | 2 | 2021 | 4 | 0.250 |
Why?
|
| Los Angeles | 4 | 2022 | 380 | 0.240 |
Why?
|
| Dry Eye Syndromes | 2 | 2014 | 5 | 0.240 |
Why?
|
| Age Distribution | 7 | 2016 | 225 | 0.230 |
Why?
|
| Intraocular Pressure | 3 | 2020 | 112 | 0.230 |
Why?
|
| Light | 2 | 2018 | 187 | 0.230 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 70 | 0.230 |
Why?
|
| Corneal Dystrophy, Juvenile Epithelial of Meesmann | 1 | 2023 | 1 | 0.230 |
Why?
|
| Incidence | 4 | 2019 | 922 | 0.220 |
Why?
|
| Nomograms | 1 | 2022 | 9 | 0.220 |
Why?
|
| Glare | 3 | 2017 | 4 | 0.200 |
Why?
|
| Cohort Studies | 7 | 2022 | 1492 | 0.200 |
Why?
|
| Health Status Disparities | 2 | 2022 | 642 | 0.200 |
Why?
|
| Vaccines | 1 | 2022 | 55 | 0.200 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 2379 | 0.190 |
Why?
|
| Sex Distribution | 5 | 2016 | 215 | 0.190 |
Why?
|
| Benchmarking | 1 | 2020 | 29 | 0.190 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2020 | 1 | 0.190 |
Why?
|
| Basic Reproduction Number | 1 | 2020 | 2 | 0.190 |
Why?
|
| Corneal Stroma | 3 | 2018 | 6 | 0.190 |
Why?
|
| Government Programs | 1 | 2020 | 29 | 0.190 |
Why?
|
| Leadership | 1 | 2020 | 76 | 0.180 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 146 | 0.180 |
Why?
|
| Eye Diseases | 1 | 2019 | 24 | 0.180 |
Why?
|
| Mothers | 1 | 2021 | 181 | 0.170 |
Why?
|
| Cultural Diversity | 1 | 2020 | 169 | 0.170 |
Why?
|
| Tonometry, Ocular | 2 | 2016 | 26 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2019 | 25 | 0.170 |
Why?
|
| Physician's Role | 1 | 2019 | 38 | 0.170 |
Why?
|
| Night Vision | 1 | 2018 | 3 | 0.170 |
Why?
|
| Color Vision | 1 | 2018 | 7 | 0.160 |
Why?
|
| Ultraviolet Rays | 4 | 2022 | 117 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.160 |
Why?
|
| Elasticity | 2 | 2017 | 38 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.160 |
Why?
|
| Anterior Eye Segment | 2 | 2019 | 8 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2019 | 238 | 0.160 |
Why?
|
| Time Factors | 6 | 2019 | 1742 | 0.150 |
Why?
|
| Diabetes Complications | 1 | 2018 | 90 | 0.150 |
Why?
|
| Ultrasonics | 2 | 2007 | 11 | 0.150 |
Why?
|
| Self Medication | 1 | 2017 | 13 | 0.150 |
Why?
|
| Blindness | 1 | 2016 | 17 | 0.140 |
Why?
|
| Vision, Low | 1 | 2016 | 13 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 494 | 0.140 |
Why?
|
| Convergence, Ocular | 1 | 2016 | 3 | 0.140 |
Why?
|
| Public Health | 1 | 2021 | 372 | 0.140 |
Why?
|
| Cataract | 3 | 2015 | 26 | 0.140 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 148 | 0.140 |
Why?
|
| Physical Examination | 1 | 2016 | 43 | 0.130 |
Why?
|
| Eye Movements | 1 | 2015 | 14 | 0.130 |
Why?
|
| Ophthalmology | 1 | 2016 | 29 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 60 | 0.130 |
Why?
|
| Caregivers | 1 | 2017 | 182 | 0.130 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 1067 | 0.120 |
Why?
|
| Debridement | 1 | 2014 | 4 | 0.120 |
Why?
|
| Elastic Tissue | 1 | 2014 | 7 | 0.120 |
Why?
|
| Color Vision Defects | 1 | 2014 | 2 | 0.120 |
Why?
|
| Solvents | 1 | 2014 | 99 | 0.120 |
Why?
|
| Body Weights and Measures | 3 | 2009 | 22 | 0.120 |
Why?
|
| United States | 3 | 2020 | 4223 | 0.120 |
Why?
|
| National Eye Institute (U.S.) | 1 | 2013 | 3 | 0.120 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 21 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2023 | 1369 | 0.110 |
Why?
|
| Fluorophotometry | 1 | 2013 | 1 | 0.110 |
Why?
|
| Statistical Distributions | 1 | 2013 | 3 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 485 | 0.110 |
Why?
|
| Conflict of Interest | 1 | 2012 | 10 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2011 | 112 | 0.110 |
Why?
|
| Editorial Policies | 1 | 2012 | 13 | 0.110 |
Why?
|
| Bibliometrics | 1 | 2012 | 17 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2012 | 18 | 0.110 |
Why?
|
| Presbyopia | 1 | 2012 | 1 | 0.110 |
Why?
|
| Disclosure | 1 | 2012 | 34 | 0.110 |
Why?
|
| Ethanol | 1 | 2014 | 192 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2013 | 286 | 0.110 |
Why?
|
| Glaucoma | 1 | 2013 | 85 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 49 | 0.100 |
Why?
|
| Sex Factors | 5 | 2014 | 898 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 145 | 0.100 |
Why?
|
| Comorbidity | 1 | 2013 | 623 | 0.090 |
Why?
|
| Aberrometry | 1 | 2010 | 1 | 0.090 |
Why?
|
| Acrylic Resins | 1 | 2010 | 7 | 0.090 |
Why?
|
| Fovea Centralis | 1 | 2010 | 3 | 0.090 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 35 | 0.090 |
Why?
|
| Age Factors | 3 | 2019 | 1033 | 0.090 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2009 | 1 | 0.080 |
Why?
|
| Iris | 1 | 2009 | 26 | 0.080 |
Why?
|
| Automation | 1 | 2009 | 22 | 0.080 |
Why?
|
| Quality of Life | 1 | 2013 | 481 | 0.080 |
Why?
|
| Risk Factors | 3 | 2016 | 3562 | 0.080 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2008 | 2 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2007 | 26 | 0.080 |
Why?
|
| Disease Progression | 2 | 2022 | 601 | 0.070 |
Why?
|
| Population Groups | 3 | 2013 | 56 | 0.070 |
Why?
|
| Interferometry | 1 | 2005 | 3 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2019 | 446 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 24 | 0.070 |
Why?
|
| Corneal Wavefront Aberration | 2 | 2018 | 2 | 0.070 |
Why?
|
| Educational Status | 2 | 2020 | 313 | 0.070 |
Why?
|
| Entrepreneurship | 1 | 2023 | 5 | 0.060 |
Why?
|
| Mydriatics | 1 | 2022 | 5 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2024 | 291 | 0.050 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2022 | 5 | 0.050 |
Why?
|
| Urban Population | 2 | 2015 | 333 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 9 | 0.050 |
Why?
|
| ROC Curve | 1 | 2022 | 138 | 0.050 |
Why?
|
| Health Surveys | 2 | 2015 | 373 | 0.050 |
Why?
|
| Contact Tracing | 1 | 2020 | 19 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 88 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 288 | 0.050 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2019 | 1 | 0.050 |
Why?
|
| Geography | 1 | 2020 | 96 | 0.050 |
Why?
|
| Eyelid Diseases | 1 | 2019 | 4 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 32 | 0.040 |
Why?
|
| Income | 1 | 2020 | 140 | 0.040 |
Why?
|
| Hospitalization | 1 | 2022 | 388 | 0.040 |
Why?
|
| Linear Models | 2 | 2009 | 275 | 0.040 |
Why?
|
| Equipment Design | 1 | 2017 | 124 | 0.040 |
Why?
|
| Esotropia | 1 | 2016 | 4 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 677 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2017 | 170 | 0.030 |
Why?
|
| Vision Tests | 1 | 2015 | 4 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 198 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 583 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 3 | 0.030 |
Why?
|
| Biometry | 1 | 2014 | 11 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 562 | 0.030 |
Why?
|
| Refractive Surgical Procedures | 1 | 2014 | 1 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 7 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 135 | 0.030 |
Why?
|
| Rose Bengal | 1 | 2013 | 3 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 218 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 16 | 0.030 |
Why?
|
| Dark Adaptation | 1 | 2013 | 16 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 105 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 885 | 0.030 |
Why?
|
| Rural Population | 1 | 2015 | 294 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 181 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 864 | 0.020 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 2 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 31 | 0.020 |
Why?
|
| Anisocoria | 1 | 2009 | 1 | 0.020 |
Why?
|
| Eye Color | 1 | 2009 | 3 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 149 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 117 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 854 | 0.020 |
Why?
|